02162 KEYMED BIO-B
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 2.90X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 9.7% | Net Margin | N/A |
| Total Debt/Equity | 28.4% | Return on Equity | N/A |
| Price/Book | 6.90X | Return on Assets | N/A |
| (HKD 71.350) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | -581.75 | -547.96 | -396.08 | -345.46 | -4,754.57 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -6.2 | -38.3 | -14.7 | +92.7 | -389.4 |
| Earnings Per Share (HKD) | -2.123 | -2.092 | -1.515 | -1.323 | -29.559 |
| Earnings Per Share Growth (%) | -1.5 | -38.0 | -14.5 | +95.5 | -104.2 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 10.337 | 9.408 | 11.767 | 13.388 | 15.963 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 716.313 | 428.124 | +67.3 | 354.095 |
| Operating Result | -520.049 | -503.391 | +3.3 | -351.44 |
| Associates | -0.674 | -5.256 | -87.2 | -4.748 |
| Profit Before Taxation | -520.723 | -508.647 | +2.4 | -356.188 |
| Taxation | 1.874 | 6.26 | -70.1 | 1.597 |
| Profit /( Loss) After Taxation | -522.597 | -514.907 | +1.5 | -357.785 |
| Minority Interests | 0.044 | 0.334 | -86.8 | 1.572 |
| Net Profit | -522.641 | -515.241 | +1.4 | -359.357 |
| Earnings Per Share () | -2.1234 | -2.0919 | +1.5 | -1.5154 |
| Announcement Date | 2026-03-26 | 2025-03-24 | NA | 2024-03-26 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
